Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/044487

Differential Canalograms Detect Outflow Changes from Trabecular Micro-Bypass Stents and Ab Interno Trabeculectomy

Hardik A Parikh·Ralitsa T. Loewen·Pritha Roy·Joel S. Schuman·Kira L. Lathrop·Nils A Loewen
View original source ↗Export metadata ↓

Abstract

The increasing prevalence of glaucoma, a leading cause of blindness, makes the development of safer and more effective treatment more urgent. Recently introduced microincisional glaucoma surgeries that enhance conventional outflow offer a favorable risk profile but can be unpredictable. Two paramount challenges are the lack of an adequate surgical training model for new surgeries and the absence of pre-or intraoperative guidance to sites of reduced flow. To address both, we developed an ex vivo training system and a differential, quantitative canalography method to assess outflow enhancement by trabecular micro-bypass (TMB) implantation or by ab interno trabeculectomy (AIT). TMB resulted in insignificant (p>0.05) outflow increases of 13{+/-}5%, 14{+/-}8%, 9{+/-}3%, and 24{+/-}9% in the inferonasal, superonasal, superotemporal, and inferotemporal quadrants. AIT caused a 100{+/-}50% (p=0.002), 75{+/-}28% (p=0.002), 19{+/-}8%, and 40{+/-}21% increase in those quadrants. AIT eyes had a 7.5 (p=0.01), 5.7 (p=0.004), 2.3, and 1.8-fold greater outflow enhancement than matching quadrants of paired TMB-implanted eyes. Quantitative canalography demonstrated that TMB, when successful, provided focal outflow enhancements, while AIT achieved a more extensive access to outflow pathways including and beyond the surgical site itself.

Source connections

Explore related subjects

PhysiologyPreprint

Keep this discovery

BibTeXRIS

Hardik A Parikh, Ralitsa T. Loewen, Pritha Roy, Joel S. Schuman, Kira L. Lathrop, Nils A Loewen. 2016-03-18. Differential Canalograms Detect Outflow Changes from Trabecular Micro-Bypass Stents and Ab Interno Trabeculectomy. https://doi.org/10.1101/044487

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2016

Lactobacillus plantarum favors the early emergence of fit and fertile adult Drosophila upon chronic undernutrition

Animals are naturally surrounded by a variety of microorganisms with which they constantly interact. Among these microbes, some live closely associated with a host and form its microbiota. These communities are now extensively studied, owing to their contributions to shaping various aspects of animal physiology. One of these commensal species, Lactobacillus plantarum, and in particular the L.p.WJL strain, has been shown to promote the growth of Drosophila larvae upon nutrient scarcity, allowing earlier metamorphosis and adult emergence compared to axenic individuals. As for many insects, conditions surrounding the post-embryonic development dictate key Drosophila adult life history traits, and adjusting developmental timing according to the environment is essential for adult fitness. The growth acceleration induced by L.p.WJL occurs in a context of poor nutrition and we wondered if this could adversely impact the fitness of Drosophila adults. Here we show that the L.p.WJL- mediated acceleration of growth is not deleterious; adults emerging after an accelerated development are as fit as their axenic siblings. Additionally, L.p.WJLs presence even leads to a lifespan extension in nutritionally challenged males. These results demonstrate that L.p.WJL is a beneficial partner for Drosophila melanogaster through its entire life cycle. This commensal bacteria allows the earlier emergence and longer survival of fit and fertile individuals and might represent one of the factors contributing to the ecological success of Drosophila.\n\nSummary statementLactobacillus plantarumWJL is beneficial to Drosophila physiology along its entire life cycle. This bacteria triggers the early emergence and longer survival of fit and fertile adults.

Physiology↗
bioRxiv2016

Disruption of Hepatocyte Jak2 leads to Spontaneous NASH in Aged Mice and Uncouples Metabolic Liver Disease from Insulin Resistance

Growth Hormone (GH) is a master regulator of metabolic homeostasis and longevity. Whole body GH insensitivity (GHI) augments insulin sensitivity, age-related disease resistance, adiposity, and occurrence of NAFLD. Conversely, acromegalic patients are prone to diabetes and increased mortality due to constitutive high levels of circulating GH. However, which tissues control the various metabolic aspects of GH physiology are unknown. Therefore, we determined the role of GH in age-related metabolic dysfunction by inducing hepatocyte- (JAK2L) or adipocyte-specific (JAK2A) GHI individually or combinatorially (JAK2LA) via deletion of Jak2, an obligate transducer of GH signaling. Aged JAK2L mice were insulin resistant but lean and had significant NASH, hepatic inflammation, and fibrosis. In contrast, JAK2A animals had increased adiposity and were completely resistant to age-associated hepatic steatosis, NASH, and insulin resistance. Interestingly, while JAK2LA mice retained enhanced whole-body insulin sensitivity, they still developed NASH to an almost identical degree as JAK2L mice but with a substantial reduction in the degree of microvesicular steatosis. Collectively, loss of adipocyte Jak2 conferred whole body insulin sensitivity even in the face of obesity and NASH. Deletion of hepatocyte Jak2 promoted NASH in aged mice without any dietary or drugs perturbations. The effect appears to be liver autonomous and cannot be overcome by the insulin sensitizing effect of adipocyte Jak2 deletion. Here, we describe the first model of spontaneous NASH that is coupled to augmented insulin sensitivity. Further, there was an inverse correlation between insulin sensitivity and the degree of microvesicular steatosis. Therefore, GH signaling independently mediates insulin/glucose and lipid homeostasis and directly regulates the development of NASH in aged mice.\n\nFinancial SupportThis study was supported by National Institutes of Health (NIH) Grants 1R01DK091276 (to E.J.W.). We also acknowledge the support of the University of California, San Francisco (UCSF) Cardiovascular Research Institute, the UCSF Diabetes Center (P30 DK063720), the UCSF Liver Center (P30 DK026743, and the James Peter Read Foundation.\n\nAbbreviations

Physiology↗
bioRxiv2016

Adipocyte JAK2 mediates hepatic insulin sensitivity and the diabetogenic action of Growth Hormone

For nearly 100 years, Growth Hormone (GH) has been known to impact insulin sensitivity and risk of diabetes. However, the tissue governing the effects of GH signaling on insulin and glucose homeostasis remains unknown. Excess GH reduces fat mass and insulin sensitivity. Conversely, GH insensitivity (GHI) is associated with increased adiposity, augmented insulin sensitivity, and protection from diabetes. Here we induce adipocyte-specific GHI through conditional deletion of Jak2 (JAK2A), an obligate transducer of GH signaling. Similar to whole-body GHI, JAK2A mice had increased adiposity and extreme insulin sensitivity. Loss of adipocyte Jak2 augmented hepatic insulin sensitivity and conferred resistance to diet-induced metabolic stress without overt changes in circulating fatty acids. While GH injections induced hepatic insulin resistance in control mice, the diabetogenic action was absent in JAK2A mice. Adipocyte GH signaling directly impinged on both adipose and hepatic insulin signal transduction. Collectively, our results show that adipose tissue governs the effects of GH on insulin and glucose homeostasis. Further, we show that JAK2 mediates liver insulin sensitivity via an extra-hepatic, adipose tissue-dependent mechanism.

Physiology↗